The Food and Drug Administration’s Federal Review of a Pediatric Muscular Dystrophy Protocol
Abstract: The Food and Drug Administration (FDA) requirements for pediatric research, “Additional Safeguards for Children in Clinical Investigations,” provide an ethical framework for whether and under what conditions children can...